These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 6419377
1. Antianginal drug trapidil (Rocornal) inhibits spreading of platelets and formation of surface-bound thrombi-like aggregates. Mazurov AV, Leytin VL, Repin VS, Smirnov VN, Taube C, Förster V. Thromb Res; 1983 Nov 01; 32(3):255-66. PubMed ID: 6419377 [Abstract] [Full Text] [Related]
2. [Inhibition of thrombocyte spreading and the formation of thrombus-like aggregates bound with substrate by the anti-anginal agent trapidil]. Mazurov AV, Leĭtin VL, Repin VS. Vopr Med Khim; 1984 Nov 01; 30(4):110-6. PubMed ID: 6438908 [Abstract] [Full Text] [Related]
3. Arachidonic acid and stable analogue of prostaglandin endoperoxides (U46619) induce platelet spreading and thrombi-like aggregate formation on a collagen substrate. Effect of fluid dynamics. Mazurov AV, Leytin VL, Repin VS, Smirnov VN, Förster W. Thromb Res; 1983 Oct 15; 32(2):189-205. PubMed ID: 6419375 [Abstract] [Full Text] [Related]
4. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2]. Mazurov AB, Leĭtin VL, Repin VS. Biull Eksp Biol Med; 1984 Nov 15; 98(11):563-6. PubMed ID: 6439262 [Abstract] [Full Text] [Related]
5. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin. Mazurov AV, Leytin VL, Repin VS, Taube C, Förster W. Biomed Biochim Acta; 1984 Nov 15; 43(8-9):S373-6. PubMed ID: 6440553 [Abstract] [Full Text] [Related]
6. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation. Heinroth I, Block HU, Mest HJ. Biomed Biochim Acta; 1984 Nov 15; 43(8-9):S389-92. PubMed ID: 6440555 [Abstract] [Full Text] [Related]
7. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)]. Block HU, Heinroth I, Giessler C, Pönicke K, Mentz P, Zehl U, Rettkowski W, Dunemann A, Förster W. Biomed Biochim Acta; 1983 Nov 15; 42(2-3):283-99. PubMed ID: 6411078 [Abstract] [Full Text] [Related]
8. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil. Mazurov AV, Menshikov MYu, Leytin VL, Tkachuk VA, Repin VS. FEBS Lett; 1984 Jul 09; 172(2):167-71. PubMed ID: 6086387 [Abstract] [Full Text] [Related]
9. Inhibition of cytosolic Ca++ mobilization in human platelets by the antianginal drug trapidil and its derivative AR 12463. Block HU, Gabbasov ZA, Pozin EY, Popov EG, Mest HJ. Biomed Biochim Acta; 1988 Jul 09; 47(12):1093-7. PubMed ID: 2855396 [Abstract] [Full Text] [Related]
10. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H, Stegmeier K. Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261 [Abstract] [Full Text] [Related]
11. Inhibition of thromboxane A2 production by trapidil and trapidil derivatives in the arachidonic acid-injected rat. Heinroth-Hoffmann I, Hauser A, Mest HJ. Prostaglandins Leukot Med; 1987 Dec 01; 30(2-3):87-92. PubMed ID: 2827194 [Abstract] [Full Text] [Related]
12. Influence of the antianginal drug trapidil and its derivative AR 12463 on arachidonic acid liberation and thromboxane formation in thrombin-stimulated platelets. Block HU, Dunemann A, Niebisch M, Mest HJ. Biomed Biochim Acta; 1988 Dec 01; 47(10-11):S141-4. PubMed ID: 3248101 [Abstract] [Full Text] [Related]
13. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets. Ohkubo S, Nakahata N, Ohizumi Y. Br J Pharmacol; 1996 Mar 01; 117(6):1095-104. PubMed ID: 8882602 [Abstract] [Full Text] [Related]
14. Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171. Vargaftig B, Joseph D, Hatmi M. Thromb Res; 1987 May 15; 46(4):509-17. PubMed ID: 3039684 [Abstract] [Full Text] [Related]
15. Phorbol ester stimulates platelet spreading and thrombi-like aggregate formation on the surface of immobilized type V collagen. Leytin VL, Misselwitz F, Avdonin PV, Podrez FA, Domogatsky SP, Tkachuk VA. Thromb Res; 1989 Aug 01; 55(3):309-18. PubMed ID: 2781531 [Abstract] [Full Text] [Related]
16. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists. Hanasaki K, Arita H. Biochem Pharmacol; 1988 Oct 15; 37(20):3923-9. PubMed ID: 2973322 [Abstract] [Full Text] [Related]
17. Two phasic generation of thromboxane A2 by the action of collagen on rat platelets. Hanasaki K, Nakano T, Arita H. Thromb Res; 1987 May 01; 46(3):425-36. PubMed ID: 2955543 [Abstract] [Full Text] [Related]
18. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets. Turini ME, Holub BJ. Biochim Biophys Acta; 1994 Jun 23; 1213(1):21-6. PubMed ID: 8011675 [Abstract] [Full Text] [Related]
19. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets. Nakano T, Hanasaki K, Arita H. J Biol Chem; 1989 Apr 05; 264(10):5400-6. PubMed ID: 2494164 [Abstract] [Full Text] [Related]
20. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Vezza R, Mezzasoma AM, Venditti G, Gresele P. Thromb Haemost; 2002 Jan 05; 87(1):114-21. PubMed ID: 11848439 [Abstract] [Full Text] [Related] Page: [Next] [New Search]